Shimizu T
Department of Neuropsychiatry, Akita University School of Medicine.
Nihon Rinsho. 1998 Feb;56(2):376-81.
Narcolepsy is a disorder of sleep with uncontrolled sleepiness and cataplexy. Its prevalence in Japanese is estimated to be 0.16-0.59%. The handicap of narcoleptic patients is even larger than that of epileptic patients. The etiology is still unknown, however, a tight association between specific HLA (DR15 and QQ6) or its genotypes (DRB11501, DRB50101, DQB10602, DQA10102) and narcolepsy was recently established. This finding raises the possibility that narcolepsy might be an immunological disorder. At present, any concrete evidence supporting this possibility is lacking. Methylphenidate and pemoline are used for controlling excessive daytime sleepiness. Some tricyclic antidepressant such as clomipramine and imipramine are effective in controlling cataplexy, sleep paralysis and hypnagogic hallucination.
发作性睡病是一种伴有无法控制的嗜睡和猝倒的睡眠障碍。据估计,其在日本的患病率为0.16 - 0.59%。发作性睡病患者的残疾程度甚至比癫痫患者更大。病因尚不清楚,然而,最近发现特定的人类白细胞抗原(DR15和QQ6)或其基因型(DRB11501、DRB50101、DQB10602、DQA10102)与发作性睡病之间存在紧密关联。这一发现增加了发作性睡病可能是一种免疫性疾病的可能性。目前,缺乏支持这一可能性的任何具体证据。哌甲酯和匹莫林用于控制日间过度嗜睡。一些三环类抗抑郁药,如氯米帕明和丙咪嗪,对控制猝倒、睡眠麻痹和入睡前幻觉有效。